| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.25 | 6e-13 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-08 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-08 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.12 | 4e-05 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |